ADPT · Forms 3, 4, 5
Insider trades at Adaptive Biotechnologies Corp
3 insiders sold $4.7M of Adaptive Biotechnologies Corp stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Adaptive Biotechnologies Corp (ADPT) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 11,581 | $24.21 | $280K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 300 | $25.45 | $8K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 11,881 | $25.61 | $304K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 6,781 | $25.57 | $173K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 5,100 | $25.82 | $132K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 11,881 | $25.50 | $303K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 9,181 | $25.35 | $233K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 2,700 | $26.07 | $70K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 11,881 | $26.41 | $314K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 11,881 | $25.66 | $305K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 11,881 | $26.40 | $314K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 9,381 | $27.36 | $257K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 1,100 | $28.21 | $31K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 901 | $29.71 | $27K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 499 | $30.53 | $15K | Form 4 | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Sell (10b5-1 plan) | 6,444 | $30.00 | $193K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 6,699 | $28.82 | $193K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 5,182 | $29.67 | $154K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 11,881 | $28.13 | $334K | Form 4 | |
| Julie Rubinstein | President and COO | Option exercise | 11,881 | $12.14 | $144K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 6,081 | $27.57 | $168K | Form 4 | |
| Julie Rubinstein | President and COO | Sell (10b5-1 plan) | 5,800 | $28.56 | $166K | Form 4 | |
| Francis Lo | Chief People Officer | Option exercise | 8,038 | $8.46 | $68K | Form 4 | |
| Francis Lo | Chief People Officer | Option exercise | 9,377 | $3.99 | $37K | Form 4 | |
| Francis Lo | Chief People Officer | Option exercise | 9,377 | $8.12 | $76K | Form 4 | |
| Francis Lo | Chief People Officer | Sell (10b5-1 plan) | 8,094 | $27.52 | $223K | Form 4 | |
| Francis Lo | Chief People Officer | Sell (10b5-1 plan) | 18,698 | $28.61 | $535K | Form 4 | |
| Francis Lo | Chief People Officer | Option exercise | 53,091 | $12.14 | $645K | Form 4 | |
| Francis Lo | Chief People Officer | Option exercise | 13,398 | $8.46 | $113K | Form 4 | |
| Francis Lo | Chief People Officer | Option exercise | 15,629 | $3.99 | $62K | Form 4 | |
| Francis Lo | Chief People Officer | Option exercise | 23,442 | $8.12 | $190K | Form 4 | |
| Francis Lo | Chief People Officer | Sell (10b5-1 plan) | 107,537 | $28.02 | $3M | Form 4 | |
| Francis Lo | Chief People Officer | Sell (10b5-1 plan) | 7,869 | $28.57 | $225K | Form 4 | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Sell (10b5-1 plan) | 1,195 | $27.00 | $32K | Form 4 | |
| Katey Einterz Owen | Director | Gift | 12,539 | Form 4 | |||
| Katey Einterz Owen | Director | Sell | 9,615 | $26.00 | $250K | Form 4 | |
| Robert Hershberg | Director | Option exercise | 15,000 | $6.32 | $95K | Form 4 | |
| Robert Hershberg | Director | Sell | 15,000 | $24.39 | $366K | Form 4 | |
| Robert Hershberg | Director | Sell | 15,664 | $24.41 | $382K | Form 4 | |
| Chad M Robins | CEO and Chairman | Option exercise | 278,676 | $6.55 | $1.8M | Form 4 | |
| Chad M Robins | CEO and Chairman | Sell | 278,472 | $24.48 | $6.8M | Form 4 | |
| Chad M Robins | CEO and Chairman | Sell | 204 | $25.14 | $5K | Form 4 | |
| Chad M Robins | CEO and Chairman | Option exercise | 321,324 | $6.55 | $2.1M | Form 4 | |
| Chad M Robins | CEO and Chairman | Sell | 318,799 | $25.08 | $8M | Form 4 | |
| Chad M Robins | CEO and Chairman | Sell | 2,525 | $25.57 | $65K | Form 4 | |
| Peter M Neupert | Director | Option exercise | 15,000 | $6.32 | $95K | Form 4 | |
| Peter M Neupert | Director | Sell | 15,000 | $25.23 | $378K | Form 4 | |
| Peter M Neupert | Director | Sell | 40,000 | $25.10 | $1M | Form 4 | |
| Peter M Neupert | Director | Sell | 69,690 | $25.16 | $1.8M | Form 4 | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Sell (10b5-1 plan) | 3,000 | $25.00 | $75K | Form 4 | |
| Susan Bobulsky | Chief Commercial Officer, MRD | Sell (10b5-1 plan) | 1,299 | $24.00 | $31K | Form 4 | |
| Harlan S Robins | Chief Scientific Officer | Option exercise | 284,800 | $6.55 | $1.9M | Form 4 | |
| Harlan S Robins | Chief Scientific Officer | Sell (10b5-1 plan) | 278,698 | $21.72 | $6.1M | Form 4 | |
| Harlan S Robins | Chief Scientific Officer | Sell (10b5-1 plan) | 213,702 | $22.12 | $4.7M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.